Uro-Gynecological Surgical Devices

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study
• Urological Surgical Devices
• Sling & Suspension Devices
• Other Urological Devices
• Gynecological Surgical Devices
• Endometrial Ablation Devices
• Endoscopes
• Hysteroscope Systems
• Fluid Management Systems
• Other Gynecological Devices
• Trocar
• Tubal Occlusion Systems
• Curettage Systems

II. EXECUTIVE SUMMARY

1. Industry Overview

• Market Outlook
• Female Demographics & Gynecological Concerns
• Table 1: Percentage Breakdown of Total Female PopulationWorldwide for Year 2005 (Based on Age Group)(includes corresponding Graph/Chart)
• Table 2: Ovarian Cancer: Global Comparison of Incidence &Mortality Rates by Select Countries (Number per 100,000women) (includes corresponding Graph/Chart)
• Table 3: Uterus Cancer: Global Comparison of Incidence &Mortality Rates by Select Countries (Number per 100,000population) (includes corresponding Graph/Chart)
• Table 4: Cervical Cancer: Global Comparison of Incidence &Mortality Rates by Select Countries (Number per 100,000population) (includes corresponding Graph/Chart)
• Market Trends & Issues
• Demand to Enhance with Minimally Invasive Procedures
• Endometrial Ablation Devices Gaining Prominence
• Enhancing Market for Urological Surgical Devices
• Increasing R&D Efforts by Manufacturers
• Regulatory Risk - A Concern for Medical DeviceCompanies
• Slower Recovery for Older Patients

2. Product Overview

• Urological Surgical Devices
• Sling & Suspension Devices
• Other Urological Surgical Devices
• Ureteral Stents
• Gynecological Surgical Devices
• Endometrial Ablation Devices
• Endoscopes
• Laparoscope
• Cystoscope
• Falloposcope
• Hysteroscope Systems
• Fluid Management Systems
• Trocar
• Tubal Occlusion Systems
• Curettage Systems
• Female Pelvic Organs: Select Surgical Procedures
• Hysteroscopy Procedure
• Laparoscopy Procedure
• Dilation & Curettage (D&C) Procedure
• Hysterectomy Procedure
• Myomectomy Procedure
• Tubal Patency Screening Procedure
• Tubal Ligation Procedure
• Urethroscopy/Ureteroscopy
• Electrosurgery
• A Peek into Women’s Pelvic Health: SurgicalTreatments
• Endometrial Ablation
• Benign-Caused Menorrhagia: Uterine BalloonTherapy (UBT)
• Urinary Incontinence
• Pelvic Organ Prolapse

3. Recent Industry Activity

• Cytyc Corporation Acquires Adiana
• Aragon Acquires VeriSure, Inc.
• Boston Scientific to Divest Part of Endosurgery Business
• Cytyc Corporation Acquires EndometriosisTreatment Device from Helica
• Teleflex Acquires Taut’s Assets
• Gyrus ACMI Collaborates with Conceptus
• Conceptus Inks Partnerships with Hysteroscope Producers
• Olympus & Conceptus Ally to Promote Hysteroscopesfor Essure®
• Vision Sciences & Medtronic Terminate Urology ProductsDistribution Agreement
• Synovis Inks Distribution Agreement with Caldera forHydrix XM
• AMS Acquires Laserscope
• C. R. Bard Takes Over Venetec International
  • ETHICON Acquires Vascular Control Systems
  • AMS Purchases Urology Technology of BioControlMedical
  • Laserscope Takes Over InnovaQuartz, Inc.
  • ACMI Corporation Signs an Agreement with MMS
  • AMS Forms Cross-Licensing Deal with Caldera Medical
  • Mentor Divests Urology Business
  • Gyrus Group Acquires ACMI
• C. R. Bard Acquired Select Assets from Genyx Medical
  • Caldera Medical Forms Alliance with MTF
  • Conceptus Signs Partnership Agreements…
  • Uroplasty Receives Approval for Urgent® PCUrological Device
  • Uroplasty Receives USFDA Approval
  • Cooper Surgical Steps into Gynecologic Surgery Market
  • Conceptus Terminates Deal Signed with Gynecare
  • Cytyc Corporation Acquires Novacept
  • AMS Acquires CryoGen

4. Product Innovations/Introductions

• AMS Receives FDA & CE Mark Approval forMiniArc™ Sling System
• Gyrus ACMI Unveils launches DUR-D DigitalFlexible Ureteroscope
• Ethicon Launches GYNECARE TVT SECUR™ Systemfor SUI Treatment
• Ethicon Unveils GYNECARE MORCELLEX TissueMorcellator Device
• Medtronic Gains FDA & CE Mark Approvals for itsInterStim® II System
• FDA Approves Use of Ethicon’s Harmonic Wave forOpen Surgical Procedures
• Caldera Adds New Prolapse Indication for T-Sling
• FDA Approves Colpexin Sphere Device forProlapse Support
• Laserscope Unveils GreenLight HPS
• New Mini-Hysteroscope from Blue Endo
• POPmesh™ from Caldera Medical
• Olympus Introduces New Endoscopes
• All-Digital Flexible Endoscope from ACMI
• Products from Uroplasty to Treat Voiding Dysfunctions

5. Focus on Select Key Players

• Gyrus ACMI Corporation (USA)
• American Medical Systems Holdings Incorporated (USA)
• Laserscope, Inc. (USA)
• Boston Scientific Corporation (USA)
• C. R. Bard, Inc. (USA)
  • Cook Urological Inc. (USA)
  • CooperSurgical, Inc. (USA)
  • Cytyc Corporation (USA)
  • Cytyc Surgical Products
  • Ethicon Inc. (USA)
  • Karl Storz GmbH & Co. KG (Germany)
  • MDMI Technologies Inc. (Canada)
  • Medtronic, Inc. (USA)
  • Microsulis Americas, Inc. (USA)
  • Olympus America Inc. (USA)
  • Olympus Surgical & Industrial America, Inc. (USA)
  • Richard Wolf GmbH (Germany)
  • Stryker Corporation (USA)
• U.S. Surgical (USA)

6. Global Market Perspective

• Table 5: World Recent Past, Current and Future Analysis forUro-Gynecological Surgical Devices by Geographic Region -US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),and Rest of World Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
• Table 6: World Long-term Projections for Uro-GynecologicalSurgical Devices by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), and Rest of WorldMarkets Independently Analyzed by Annual Sales in US$ Millionfor Years 2011 through 2015 (includes correspondingGraph/Chart)
• Table 7: World 10-Year Perspective for Uro-GynecologicalSurgical Devices by Geographic Region - PercentageBreakdown of Dollar Sales for US, Canada, Japan, Europe,Asia Pacific (excluding Japan), and Rest of World Marketsfor the Years 2001, 2006 and 2010 (includescorresponding Graph/Chart)
• Table 8: World Recent Past, Current and Future Analysis forUrological Surgical Devices by Geographic Region - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan),and Rest of World Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
• Table 9: World Long-term Projections for Urological SurgicalDevices by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), and Rest of World MarketsIndependently Analyzed by Annual Sales in US$ Million for Years2011 through 2015 (includes corresponding Graph/Chart)
• Table 10: World 10-Year Perspective for Urological SurgicalDevices by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe, Asia Pacific(excluding Japan), and Rest of World Markets for the Years 2001,2006 and 2010 (includes corresponding Graph/Chart)
• Table 11: World Recent Past, Current and Future Analysis forUrological Surgical Devices by Product Segment- Sling &Suspension Devices and Other Urological Devices MarketsIndependently Analyzed by Annual Sales in US$ Millionfor the Years 2001 through 2010 (includes correspondingGraph/Chart)
• Table 12: World Long-term Projections for Urological SurgicalDevices by Product Segment - Sling & Suspension Devices andOther Urological Devices Markets Independently Analyzed byAnnual Sales in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
• Table 13: World 10-Year Perspective for Urological SurgicalDevices by Product Segment- Sling & Suspension Devices andOther Urological Devices Markets for the Years 2001,2006 and 2010
• Table 14: World Recent Past, Current and Future Analysisfor Sling & Suspension Devices by Geographic Region -US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),and Rest of World Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
• Table 15: World Long-term Projections for Sling & SuspensionDevices by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), and Rest of World MarketsIndependently Analyzed by Annual Sales in US$ Million forYears 2011 through 2015 (includes correspondingGraph/Chart)
• Table 16: World 10-Year Perspective for Sling & SuspensionDevices by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe, Asia Pacific(excluding Japan), and Rest of World Markets for theYears 2001, 2006 and 2010 (includecorrespondingGraph/Chart)
• Table 17: World Recent Past, Current and Future Analysisfor Other Urological Devices by Geographic Region - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan),and Rest of World Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
• Table 18: World Long-term Projections for Other UrologicalDevices by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), and Rest of World MarketsIndependently Analyzed by Annual Sales in US$ Million forYears 2011 through 2015 (includes correspondingGraph/Chart)
• Table 19: World 10-Year Perspective for Other UrologicalDevices by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe, Asia Pacific(excluding Japan), and Rest of World Markets for the Years 2001,2006 and 2010 (includes corresponding Graph/Chart)
• Table 20: World Recent Past, Current and Future Analysisfor Gynecological Surgical Devices by Geographic Region -US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),and Rest of World Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
• Table 21: World Long-term Projections for GynecologicalSurgical Devices by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), and Rest of WorldMarkets Independently Analyzed by Annual Sales in US$Million for Years 2011 through 2015 (includes correspondingGraph/Chart)
• Table 22: World 10-Year Perspective for GynecologicalSurgical Devices by Geographic Region - PercentageBreakdown of Dollar Sales for US, Canada, Japan, Europe,Asia Pacific (excluding Japan), and Rest of World Marketsfor the Years 2001, 2006 and 2010 (includes correspondingGraph/Chart)
• Table 23: World Recent Past, Current and Future Analysis forGynecological Surgical Devices by Product Segment-Endometric Ablation Devices, Endoscopes, HysteroscopeSystems, Fluid Management Systems, and Other GynecologicalDevices Markets Independently Analyzed by Annual Sales inUS$ Million for the Years 2001 through 2010 (includescorresponding Graph/Chart)
• Table 24: World Long-term Projections for GynecologicalSurgical Devices by Product Segment- Endometric AblationDevices, Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other Gynecological DevicesMarkets Independently Analyzed by Annual Sales inUS$ Million for Years 2011 through 2015 (includescorresponding Graph/Chart)
• Table 25: World 10-Year Perspective for Gynecological SurgicalDevices by Product Segment- Endometric Ablation Devices,Endoscopes, Hysteroscope Systems, Fluid Management Systems,and Other Gynecological Devices Markets for the Years 2001,2006 and 2010 (includes corresponding Graph/Chart)
• Table 26: World Recent Past, Current and Future Analysisfor Endometrial Ablation Devices by Geographic Region -US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),and Rest of World Markets Independently Analyzed by AnnualSales in US$ Million for the Years 2001 through 2010(includes corresponding Graph/Chart)
• Table 27: World Long-term Projections for EndometrialAblation Devices by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), and Rest of WorldMarkets Independently Analyzed by Annual Sales in US$ Millionfor Years 2011 through 2015 (includes correspondingGraph/Chart)
• Table 28: World 10-Year Perspective for Endometrial AblationDevices by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe,Asia Pacific(excluding Japan), and Rest of World Markets for the Years 2001,2006 and 2010 (includes corresponding Graph/Chart)
• Table 29: World Recent Past, Current and Future Analysis forEndoscopes by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), and Rest of WorldMarkets Independently Analyzed by Annual Sales inUS$ Million for the Years 2001 through 2010(includes corresponding Graph/Chart)
• Table 30: World Long-term Projections for Endoscopes byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), and Rest of World Markets IndependentlyAnalyzed by Annual Sales in US$ Million for Years 2011through 2015 (includes corresponding Graph/Chart)
• Table 31: World 10-Year Perspective for Endoscopes byGeographic Region - Percentage Breakdown of Dollar Salesfor US, Canada, Japan, Europe, Asia Pacific (excluding Japan),and Rest of World Markets for the Years 2001, 2006 and 2010(includes corresponding Graph/Chart)
• Table 32: World Recent Past, Current and Future Analysis forHysteroscope Systems by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), andRest of World Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
• Table 33: World Long-term Projections for HysteroscopeSystems by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), and Rest of World MarketsIndependently Analyzed by Annual Sales in US$ Million forYears 2011 through 2015 (includes correspondingGraph/Chart)
• Table 34: World 10-Year Perspective for Hysteroscope Systemsby Geographic Region - Percentage Breakdown of Dollar Salesfor US, Canada, Japan, Europe, Asia Pacific (excluding Japan),and Rest of World Markets for the Years 2001, 2006 and 2010(includes corresponding Graph/Chart)
• Table 35: World Recent Past, Current and Future Analysisfor Fluid Management Systems by Geographic Region -US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),and Rest of World Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
• Table 36: World Long-term Projections for Fluid ManagementSystems by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), and Rest of World MarketsIndependently Analyzed by Annual Sales in US$ Million forYears 2011 through 2015 (includes correspondingGraph/Chart)
• Table 37: World 10-Year Perspective for Fluid ManagementSystems by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe, Asia Pacific(excluding Japan), and Rest of World Markets for the Years 2001,2006 and 2010 (includes corresponding Graph/Chart)
• Table 38: World Recent Past, Current and Future Analysis forOther Gynecological Devices by Geographic Region - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan),and Rest of World Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
• Table 39: World Long-term Projections for Other GynecologicalDevices by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), and Rest of World MarketsIndependently Analyzed by Annual Sales in US$ Million forYears 2011 through 2015 (includes correspondingGraph/Chart)
• Table 40: World 10-Year Perspective for Other GynecologicalDevices by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe, Asia Pacific(excluding Japan), and Rest of World Markets for the Years 2001,2006 and 2010 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Female Demographics
  • Table 41: Percentage Breakdown of FemalePopulation in the US by Age Group: 2006(includes corresponding Graph/Chart)
  • Current Scenario in the US GynecologicalDevices Market
  • Table 42: Number of GEA Procedures (2005-2007)in the US (includes corresponding Graph/Chart)
  • Major Trends & Issues
  • Increasing Acceptance of Alternative Proceduresto Hysterectomy
  • Bright Prospects for Urological Surgical Devices
  • Least-Invasive Surgical Procedures Drivethe US Market
  • Demographics to Play a Major Role
  • Table 43: Prevalence of Various UrologicalDisorders in Females over 65 Years(includes corresponding Graph/Chart)
  • Gynecological Disorders in US Women
  • Table 44: Gynecological Cancer in the US: Incidence &Mortality Rates of Various Cancersfor the Year 2005(includes corresponding Graph/Chart)
  • Table 45: Gynecological Cancer in the US: Numberof New Cancer Cases Diagnosed for the Year2004 (includes corresponding Graph/Chart)
  • Table 46: Cervical Cancer in the US: Comparison ofIncidence & Mortality Rates by Select Race/Ethnicity forYear 2002 (includes corresponding Graph/Chart)
  • Table 47: Select Surgical Procedures Performed in theUS for the Year 2005 (Proceduresin Thousand)
  • Hysterectomy in the United States
  • Major Reasons for Hysterectomy Proceduresin the US (Based on Age Group)
  • Table 48: Hysterectomy Procedures in the US -Percentage Breakdown by Causes/Disorders(includes corresponding Graph/Chart)
  • Table 49: US Recent Past, Current and Future Analysisfor Hysterectomy by Procedure Types - AbdominalHysterectomy, and Vaginal Hysterectomy IndependentlyAnalyzed by Procedure Number in Thousand for theYears 2001 through 2010 (includes correspondingGraph/Chart)
  • Table 50: US Recent Past, Current and FutureAnalysis for Hysteroscopy by Procedure Types -Diagnostic Hysteroscopy, and Operative HysteroscopyIndependently Analyzed by Procedure Number inThousand for the Years 2001 through 2010(includes corresponding Graph/Chart)
  • Glimpse of Medicare Reimbursements in the US
  • Table 51: Medicare Reimbursements forHysterectomy Procedures for the Year 2005
  • Table 52: Medicare Reimbursements for EndometrialAblation Procedures for the Year 2005
  • Table 53: Medicare Reimbursements for Vaginal VaultSupport (AVESTA® Procedure) for the Year 2005
  • Table 54: Medicare Reimbursements for Uterine Suspension(UPLIFT Procedure) for the Year 2005
  • Table 55: Medicare Reimbursements for Uterine ProlapseRepair (ELEVEST® Procedure) for the Year 2005
  • Major Players
  • Table 56: US Market for Sling Systems: Market Shares ofMajor Players - Johnson & Johnson, American MedicalSystems, Boston Scientific Corporation, C.R. Bard, Inc,Cook Urological Inc Mentor Corporation, and Others forthe Years 2004 & 2005 (includes correspondingGraph/Chart)
  • Table 57: US Market for Suspension Systems: MarketShares of Major Players - Boston Scientific Corporation,C.R. Bard, Inc, CooperSurgical, Inc, and Othersfor the Years 2005 & 2006 (includescorresponding Graph/Chart)
  • Table 58: US Market for Ablation Systems: Market Sharesof Major Players - American Medical Systems, BostonScientific Corporation, Johnson & Johnson, Microsulis,and Others for the Years 2005 & 2006 (includescorresponding Graph/Chart)
  • Table 59: US Market for Endoscopic Products: MarketShares of Major Players - ACMI, Johnson & Johnson,Karl Storz Endoscope-America, Inc, Richard WolfInstruments, United States Surgical, and Others for theYears 2005 & 2006 (includes correspondingGraph/Chart)
  • Table 60: US Market for Hysteroscope Systems: MarketShares of Major Players - ACMI, CooperSurgical, Inc,Johnson & Johnson, and Others for the Years 2005 &2006 (includes corresponding Graph/Chart)
  • Table 61: US Market for Fluid Management Systems:Market Shares of Major Players - ACMI, AmericanMedical Systems, Johnson & Johnson, and Others for theYears 2005 & 2006 (includes correspondingGraph/Chart)
  • Table 62: US Market for Other Gynecological Products:Market Shares of Major Players - ACMI, AmericanMedical Systems, Boston Scientific Corporation, CooperSurgical, Inc, United States Surgical, and Others for theYears 2005 & 2006 (includes correspondingGraph/Chart)
  • Select Products from Major US Companies inRespective Market Segments
  • Strategic Corporate Developments
  • Product Launches
  • Key Players
• B. Market Analytics
  • Table 63: US Recent Past, Current and Future Analysisfor Uro-Gynecological Surgical Devices by ProductGroup/Segment - Urological Surgical Devices (Sling &Suspension Devices, and Other Urological Devices),Gynecological Surgical Devices (Endometrial AblationDevices, Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other GynecologicalDevices) Markets Independently Analyzed by AnnualSales in US$ Million for the Years 2001 through 2010(includes corresponding Graph/Chart)
  • Table 64: US Long-term Projections for Uro-GynecologicalSurgical Devices by Product Group/Segment - UrologicalSurgical Devices (Sling & Suspension Devices, and OtherUrological Devices), Gynecological Surgical Devices(Endometrial Ablation Devices, Endoscopes, HysteroscopeSystems, Fluid Management Systems, and Other GynecologicalDevices) Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • Table 65: US 10-Year Perspective for Uro-GynecologicalSurgical Devices by Product Group/Segment - PercentageBreakdown of Dollar Sales for Urological SurgicalDevices (Sling & Suspension Devices, and OtherUrological Devices), Gynecological Surgical Devices(Endometrial Ablation Devices, Endoscopes, HysteroscopeSystems, Fluid Management Systems, and OtherGynecological Devices) Markets forthe Years 2001, 2006and 2010 (includes corresponding Graph/Chart)

2. Canada

• A. Market Analysis
  • Market Overview
  • Female Demographics
  • Table 66: Percentage Breakdown of FemalePopulation in Canada by Age Group: 2006(includes corresponding Graph/Chart)
  • Table 67: Number of New Gynecological CancerCases Diagnosed in Canada in 2004
  • MDMI Technologies Inc. - A Key Player
• B. Market Analytics
  • Table 68: Canadian Recent Past, Current and FutureAnalysis for Uro-Gynecological Surgical Devices byProduct Group/Segment - Urological Surgical Devices(Sling & Suspension Devices, and Other UrologicalDevices), Gynecological Surgical Devices (EndometrialAblation Devices, Endoscopes, Hysteroscope Systems,Fluid Management Systems, and Other GynecologicalDevices) Markets Independently Analyzed by AnnualSales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
  • Table 69: Canadian Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment - Urological Surgical Devices (Sling &Suspension Devices, and Other Urological Devices),Gynecological Surgical Devices (Endometrial AblationDevices, Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other Gynecological Devices)Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • Table 70: Canadian 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/Segment - Percentage Breakdown of Dollar Sales forUrological Surgical Devices (Sling & SuspensionDevices, and Other Urological Devices), GynecologicalSurgical Devices (Endometrial Ablation Devices,Endoscopes, Hysteroscope Systems, Fluid ManagementSystems, and Other Gynecological Devices) Marketsfor the Years 2001, 2006 and 2010 (includescorresponding Graph/Chart)

3. Japan

• A. Market Analysis
  • Market Overview
  • Female Demographics
  • Table 71: Percentage Breakdown of FemalePopulation in Japan by Age Group: 2006(includes corresponding Graph/Chart)
• B. Market Analytics
  • Table 72: Japanese Recent Past, Current and FutureAnalysis for Uro-Gynecological Surgical Devices byProduct Group/Segment - Urological Surgical Devices(Sling & Suspension Devices, and Other UrologicalDevices), Gynecological Surgical Devices (EndometrialAblation Devices, Endoscopes, Hysteroscope Systems,Fluid Management Systems, and Other GynecologicalDevices) Markets Independently Analyzed by AnnualSales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
  • Table 73: Japanese Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment -Urological Surgical Devices (Sling & Suspension Devices,and Other Urological Devices), Gynecological SurgicalDevices (Endometrial Ablation Devices, Endoscopes,Hysteroscope Systems, Fluid Management Systems, andOther Gynecological Devices) Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million forYears 2011 through 2015 (includes correspondingGraph/Chart)
  • Table 74: Japanese 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/Segment -Percentage Breakdown of Dollar Sales for UrologicalSurgical Devices (Sling & Suspension Devices, and OtherUrological Devices), Gynecological Surgical Devices(Endometrial Ablation Devices, Endoscopes, HysteroscopeSystems,Fluid Management Systems, and OtherGynecological Devices) Markets for the Years 2001, 2006and 2010 (includes corresponding Graph/Chart)

4. Europe

• A. Market Analysis
  • Market Overview
  • Female Demographics
  • Table 75: Percentage Breakdown of Total FemalePopulation of European Union for the Year 2005(Based on Age Group) (includes correspondingGraph/Chart)
  • Table 76: Percentage Breakdown of Total FemalePopulation of European Union for the Year 2005by Member Countries (Based on Age Group)
  • Gynecological Cancer Statistics
  • Table 77: Mortality Rate of Cervical Cancer in SelectEuropean Regions for the Year 2000 (Number per100,000 women) (includes correspondingGraph/Chart)
  • Current Scenario in the European GynecologicalDevices Market
• B. Market Analytics
  • Table 78: European Recent Past, Current and FutureAnalysis for Uro-Gynecological Gynecological Devices byGeographic Region - France, Germany, UK, Italy, andRest of Europe Markets Independently Analyzed by AnnualSales in US$ Million for the Years 2001 through 2010(includes corresponding Graph/Chart)
  • Table 79: European Long-term Projections for Uro-Gynecological Devices by Geographic Region - France,Germany, UK, Italy, and Rest of Europe Markets IndependentlyAnalyzed by Annual Sales in US$ Million for Years 2011through 2015 (includes corresponding Graph/Chart)
  • Table 80: European Recent Past, Current and FutureAnalysis for Uro-Gynecological Surgical Devices byProduct Group/Segment - Urological Surgical Devices(Sling & Suspension Devices, and Other UrologicalDevices), Gynecological Surgical Devices (EndometrialAblation Devices, Endoscopes, Hysteroscope Systems,Fluid Management Systems, and Other GynecologicalDevices) Markets Independently Analyzed by AnnualSales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
  • Table 81: European Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment -Urological Surgical Devices (Sling & Suspension Devices,and Other Urological Devices), Gynecological SurgicalDevices (Endometrial Ablation Devices, Endoscopes,Hysteroscope Systems, Fluid Management Systems, and OtherGynecological Devices) Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2011through 2015 (includes corresponding Graph/Chart)
  • Table 82: European 10-Year Perspective for Uro- GynecologicalDevices by Geographic Region - Percentage Breakdown ofDollar Sales for France, Germany, UK, Italy, and Rest ofEurope Markets for the Years 2001, 2006 and 2010(includes corresponding Graph/Chart)
  • Table 83: European 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group /Segment - Percentage Breakdown of Dollar Sales forUrological Surgical Devices (Sling & Suspension Devices,and Other Urological Devices), Gynecological SurgicalDevices (Endometrial Ablation Devices, Endoscopes,Hysteroscope Systems, Fluid Management Systems, andOther Gynecological Devices) Markets for the Years 2001,2006 and 2010 (includes corresponding Graph/Chart)

4a. France

• A. Market Analysis
  • Market Overview
  • Female Demographics
  • Table 84: Percentage Breakdown of FemalePopulation in France by Age Group: 2006(includes corresponding Graph/Chart)
  • Select Diagnostic Procedures Performed inFrance in 2005
• B. Market Analytics
  • Table 85: French Recent Past, Current and FutureAnalysis for Uro-Gynecological Surgical Devices byProduct Group/Segment - Urological Surgical Devices(Sling & Suspension Devices, and Other UrologicalDevices), Gynecological Surgical Devices (EndometrialAblation Devices, Endoscopes, Hysteroscope Systems,Fluid Management Systems, and Other GynecologicalDevices) Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001through 2010 (includes correspondingGraph/Chart)
  • Table 86: French Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment -Urological Surgical Devices (Sling & Suspension Devices,and Other Urological Devices), Gynecological SurgicalDevices (Endometrial Ablation Devices, Endoscopes,Hysteroscope Systems, Fluid Management Systems, andOther Gynecological Devices) Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million forYears 2011 through 2015 (includes correspondingGraph/Chart)
  • Table 87: French 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/Segment - Percentage Breakdown of Dollar Sales forUrological Surgical Devices (Sling & SuspensionDevices, and Other Urological Devices), GynecologicalSurgical Devices (Endometrial Ablation Devices,Endoscopes, Hysteroscope Systems,Fluid ManagementSystems, and Other Gynecological Devices) Marketsfor the Years 2001, 2006 and 2010 (includescorresponding Graph/Chart)

4b. Germany

• A. Market Analysis
  • Market Overview
  • Female Demographics
  • Table 88: Percentage Breakdown of FemalePopulation in Germany by Age Group: 2006(includes corresponding Graph/Chart)
  • Select Diagnostic Procedures Performed inGermany in 2005
  • Key Players
• B. Market Analytics
  • Table 89: German Recent Past, Current and FutureAnalysis for Uro-Gynecological Surgical Devices byProduct Group/Segment - Urological Surgical Devices(Sling & Suspension Devices, and Other UrologicalDevices), Gynecological Surgical Devices (EndometrialAblation Devices, Endoscopes, Hysteroscope Systems,Fluid Management Systems, and Other GynecologicalDevices) Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001through 2010 (includes correspondingGraph/Chart)
  • Table 90: German Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment - Urological Surgical Devices (Sling &Suspension Devices, and Other Urological Devices),Gynecological Surgical Devices (Endometrial AblationDevices, Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other Gynecological Devices)Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • Table 91: German 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/Segment - Percentage Breakdown of Dollar Sales forUrological Surgical Devices (Sling & Suspension Devices,and Other Urological Devices), Gynecological SurgicalDevices (Endometrial Ablation Devices, Endoscopes,Hysteroscope Systems, Fluid Management Systems, andOther Gynecological Devices) Markets for the Years2001, 2006 and 2010 (includes correspondingGraph/Chart)

4c. The United Kingdom

• A. Market Analysis
  • Market Overview
  • Female Demographics
  • Table 92: Percentage Breakdown of Female Populationin the UK for Year 2006 (Based on Age Group)(includes corresponding Graph/Chart)
  • Select Diagnostic Procedures Performed in the UKin 2005
  • UK Gynecological Cancer Market
  • Table 93: Mortality Rates of GynecologicalCancer Cases in the UK in 2004 (includescorresponding Graph/Chart)
  • Table 94: Number of Gynecological Cancer CasesDiagnosed in the UK in 2002 (includescorresponding Graph/Chart)
  • New UK NICE Clinical Guidelines PromoteEndometrial Ablation for HMB
  • Embolisation - Ideal Alternative to HysterectomyProcedures
  • Strategic Corporate Developments
  • Femcare Group - A Key Player
• B. Market Analytics
  • Table 95: UK Recent Past, Current and Future Analysisfor Uro-Gynecological Surgical Devices by ProductGroup/ Segment - Urological Surgical Devices (Sling &Suspension Devices, and Other Urological Devices),Gynecological Surgical Devices (Endometrial AblationDevices, Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other Gynecological Devices)Markets Independently Analyzed by Annual Sales inUS$ Million for the Years 2001 through 2010 (includescorresponding Graph/Chart)
  • Table 96: UK Long-term Projections for Uro-GynecologicalSurgical Devices by Product Group/Segment - UrologicalSurgical Devices (Sling & Suspension Devices, and OtherUrological Devices), Gynecological Surgical Devices(Endometrial Ablation Devices, Endoscopes, HysteroscopeSystems, Fluid Management Systems, and Other GynecologicalDevices) Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • Table 97: UK 10-Year Perspective for Uro- GynecologicalSurgical Devices by Product Group/Segment - PercentageBreakdown of Dollar Sales for Urological Surgical Devices(Sling & Suspension Devices, and Other UrologicalDevices), Gynecological Surgical Devices (EndometrialAblation Devices, Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other Gynecological Devices)Markets for the Years 2001, 2006 and 2010 (includescorresponding Graph/Chart)

4d. Italy

• A. Market Analysis
  • Market Overview
  • Female Demographics
  • Table 98: Percentage Breakdown of FemalePopulation in Italy by Age Group: 2006(includes corresponding Graph/Chart)
  • Select Diagnostic Procedures Performed in Italyin 2005
• B. Market Analytics
  • Table 99: Italian Recent Past, Current and Future Analysisfor Uro-Gynecological Surgical Devices by ProductGroup/Segment - Urological Surgical Devices (Sling &Suspension Devices, and Other Urological Devices),Gynecological Surgical Devices (Endometrial AblationDevices, Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other Gynecological Devices)Markets Independently Analyzed by Annual Sales inUS$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
  • Table 100: Italian Long-term Projections for Uro-GynecologicalSurgical Devices by Product Group/Segment - UrologicalSurgical Devices (Sling & Suspension Devices, and OtherUrological Devices), Gynecological Surgical Devices(Endometrial Ablation Devices, Endoscopes, HysteroscopeSystems, Fluid Management Systems, and Other GynecologicalDevices) Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • Table 101: Italian 10-Year Perspective for Uro-GynecologicalSurgical Devices by Product Group/Segment - PercentageBreakdown of Dollar Sales for Urological Surgical Devices(Sling & SuspensionDevices, and Other Urological Devices),Gynecological Surgical Devices (Endometrial AblationDevices, Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other Gynecological Devices)Markets for the Years 2001, 2006 and 2010 (includescorresponding Graph/Chart)

4e. Rest of Europe

• Market Analysis
• Table 102: Rest of Europe Recent Past, Current andFuture Analysis for Uro-Gynecological SurgicalDevices by Product Group/Segment - UrologicalSurgical Devices (Sling & Suspension Devices,and Other Urological Devices), GynecologicalSurgical Devices (Endometrial Ablation Devices,Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other GynecologicalDevices) Markets Independently Analyzed byAnnual Sales in US$ Million for the Years 2001through 2010 (includes correspondingGraph/Chart)
• Table 103: Rest of Europe Long-term Projections forUro-Gynecological Surgical Devices by ProductGroup/Segment - Urological Surgical Devices (Sling &Suspension Devices, and Other Urological Devices),Gynecological Surgical Devices (Endometrial AblationDevices, Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other GynecologicalDevices) Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years2011 through 2015 (includes correspondingGraph/Chart)
• Table 104: Rest of Europe 10-Year Perspectivefor Uro-Gynecological Surgical Devices byProduct Group / Segment - Percentage Breakdownof Dollar Sales for Urological Surgical Devices(Sling & Suspension Devices, and Other UrologicalDevices), Gynecological Surgical Devices(Endometrial Ablation Devices, Endoscopes,Hysteroscope Systems, Fluid ManagementSystems, and Other Gynecological Devices)Markets for the Years 2001, 2006 and 2010(includes corresponding Graph/Chart)

5. Asia-Pacific

• A. Market Analysis
  • Market Overview
  • Table 105: Percentage Breakdown of TotalFemale Population for Select Asian Countriesfor the Year 2006 (Based on Age Group)
  • Glance at Chinese and Indian Markets
  • A Peek Into Australian Market
  • Table 106: Incidence Rates of GynecologicalCancer in Australia for the Year 2005(includes corresponding Graph/Chart)
  • Table 107: Mortality Rates of GynecologicalCancer in Australia for the Year 2004(includes corresponding Graph/Chart)
  • Table 108: Risk of Developing GynecologicalCancer Among Australian Women
• B. Market Analytics
  • Table 109: Asia Pacific Recent Past, Current and FutureAnalysis for Uro-Gynecological Surgical Devices byProduct Group/Segment - Urological Surgical Devices(Sling & Suspension Devices, and Other UrologicalDevices), Gynecological Surgical Devices (EndometrialAblation Devices, Endoscopes, Hysteroscope Systems,Fluid Management Systems, and Other GynecologicalDevices) Markets Independently Analyzed by AnnualSales in US$ Million for the Years 2001 through2010 (includes corresponding Graph/Chart)
  • Table 110: Asia-Pacific Long-term Projections for Uro-Gynecological Surgical Devices by Product Group/Segment - Urological Surgical Devices (Sling &Suspension Devices, and Other Urological Devices),Gynecological Surgical Devices (Endometrial AblationDevices, Endoscopes, Hysteroscope Systems, FluidManagement Systems, and Other Gynecological Devices)Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • Table 111: Asia Pacific 10-Year Perspective for Uro-Gynecological Surgical Devices by Product Group/Segment - Percentage Breakdown of Dollar Sales forUrological Surgical Devices (Sling & Suspension Devices, andOther Urological Devices), Gynecological Surgical Devices(Endometrial Ablation Devices, Endoscopes, HysteroscopeSystems, Fluid Management Systems, and OtherGynecological Devices) Markets for the Years 2001, 2006and 2010 (includes corresponding Graph/Chart)

6. Rest of World

• A. Market Analysis
  • Strategic Corporate Developments
• B. Market Analytics
  • Table 112: Rest of World Recent Past, Current andFuture Analysis for Uro-Gynecological SurgicalDevices by Product Group/Segment - UrologicalSurgical Devices (Sling & Suspension Devices, andOther Urological Devices), Gynecological SurgicalDevices (Endometrial Ablation Devices, Endoscopes,Hysteroscope Systems,Fluid Management Systems, andOther Gynecological Devices) Markets IndependentlyAnalyzed by Annual Sales in US$ Million for theYears 2001 through 2010 (includes correspondingGraph/Chart)
  • Table 113: Rest of World Long-term Projectionsfor Uro-Gynecological Surgical Devices byProduct Group/Segment - Urological SurgicalDevices (Sling & Suspension Devices, and OtherUrological Devices), Gynecological Surgical Devices(Endometrial Ablation Devices, Endoscopes,Hysteroscope Systems, Fluid Management Systems,and Other Gynecological Devices) MarketsIndependently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through2015 (includes corresponding Graph/Chart)
  • Table 114: Rest of World 10-Year Perspective forUro-Gynecological Surgical Devices by ProductGroup /Segment - Percentage Breakdown ofDollar Sales for Urological Surgical Devices(Sling & Suspension Devices, and Other UrologicalDevices), Gynecological Surgical Devices(Endometrial Ablation Devices, Endoscopes,Hysteroscope Systems, Fluid ManagementSystems, and Other Gynecological Devices)Markets for the Years 2001, 2006 and 2010(includes corresponding Graph/Chart)

IV. COMPETITION

• 1. Acumen Surgical Pvt., Ltd. (Pakistan)
• 2. Amaax International (Pakistan)
• 3. American Medical Systems Holdings, Inc. (USA)
  • Table 115: Annual Sales Analysis: 2004-2006(In US$ million)
  • Laserscope,Inc.(USA)
• 4. Anand Medicaids Private Limited (India)
• 5. Aragon Surgical, Inc. (USA)
• 6. ArthroCare Corporation (USA)
  • Table 116: Half Yearly Sales Analysis: 2005-2006 (H1)(In US$ million)
  • Table 117: Annual Sales Analysis: 2004-2005(In US$ million)
  • Table 118: Annual Sales Analysis by Quarter:2004-2005 (In US$ million)
• 7. B. Braun Melsungen AG (Germany)
• 8. Blue Endo (USA)
• 9. BOSS Instruments Ltd. (USA)
• 10. Boston Scientific Corporation (USA)
  • Table 119: Annual Sales Analysis: 2004-2006(In US$ million)
  • Table 120: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
  • Table 121: Annual Sales Analysis by Segment:2006 Vs. 2005 (In US$ million)
  • Table 122: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
  • Table 123: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
  • Table 124: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
  • Table 125: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
  • Boston Scientific Galway (Ireland)
• 11. C. R. Bard, Inc. (USA)
  • Table 126: Annual Sales Analysis: 2004-2006(In US$ million)
  • Table 127: Annual Sales Analysis by BusinessSegment: 2006 Vs. 2005 (In US$ million)
  • Table 128: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
  • Table 129: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
  • Table 130: Annual Sales Analysis by BusinessSegment: 2005 Vs. 2004 (In US$ million)
  • Table 131: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
  • Table 132: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
  • Bard Medical Division (USA)
  • Davol, Inc. (USA)
• 12. Caldera Medical, Inc. (USA)
• 13. Coloplast A/S (Denmark)
• 14. Conceptus, Inc. (USA)
  • Table 133: Half Yearly Sales Analysis2005-2006 (H1)
• 15. Conmed Corporation (USA)
  • Table 134: Market Share Analysis by Product:2005 Vs. 2004 (% Breakdown of Value Sales)
  • Table 135: Annual Sales Analysis: 2004-2006(In US$ million)
  • Table 136: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
  • Table 137: Annual Sales Analysis by Product2006 Vs. 2005 (In US$ million)
  • Table 138: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
  • Table 139: Annual Sales Analysis by Product:2005 Vs. 2004 (In US$ million)
  • Table 140: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
• 16. Cook Group, Inc. (USA)
  • Cook Endoscopy, Inc. (USA)
  • Cook Urological, Inc. (USA)
• 17. CooperSurgical, Inc. (USA)
• 18. Cytyc Corporation (USA)
  • Table 141: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ million)
  • Table 142: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
  • Table 143: Annual Sales Analysis by Segment2006 Vs. 2005 (In US$ million)
  • Table 144: Quarterly Sales Analysis: 2006 Vs. 2005(In US$ million)
  • Table 145: Annual Sales Analysis: 2004-2005(In US$ million)
  • Table 146: Annual Sales Analysis by Quarter:2004-2005 (In US$ million)
  • Table 147: Annual Sales Analysis by Segment:2004-2005 (In US$ million)
  • Cytyc Surgical Products (USA)
• 19. Eisner USA, Inc. (USA)
• 20. Endocare, Inc. (USA)
  • Table 148: Half Yearly Sales Analysis: 2005-2006 (H1)(In US$ million)
  • Table 149: Half Yearly Sales Analysis by Product:2005-2006 (H1) (In US$ million)
  • Table 150: Annual Sales Analysis: 2004-2005(In US$ million)
  • Table 151: Annual Sales Analysis by Quarter:2004-2005 (In US$ million)
  • Table 152: Annual Sales Analysis by GeographicRegion: 2004-2005 (In US$ million)
• 21. Femcare-Nikomed Ltd. (United Kingdom)
• 22. Gyrus Group PLC (UK)
  • Table 153: Half yearly Sales Analysis: 2005-2006 (H1)(In £ million)
  • Table 154: Annual Sales Analysis: 2004-2005(In £ million)
  • Table 155: Annual Sales Analysis by Segment:2004-2005 (In £ million)
  • Gyrus ACMI Corporation (USA)
• 23. Immersion Medical, Inc. (USA)
• 24. Integra LifeSciences Holdings Corporation (USA)
  • Table 156: Nine Months Sales Analysis: 2006 Vs. 2005(Nine Months Ended, September) (In US$ million)
  • Table 157: Nine Months Sales Analysis by Segment:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
  • Table 158: Nine Months Sales Analysis by GeographicRegion: 2006 Vs. 2005 (Nine Months Ended,September) (In US$ million)
  • Table 159: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
  • Table 160: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
  • Table 161: Annual Sales Analysis by Product:2005 Vs. 2004 (In US$ million)
• 25. Intuitive Surgical, Inc. (USA)
  • Table 162: Half Yearly Sales Analysis:2005-2006 (H1) (In US$ million)
  • Table 163: Annual Sales Analysis: 2004-2005(In US$ million)
• 26. Jindal Medical & Scientific Instruments Company(Pvt.,) Ltd. (India)
• 27. Johnson & Johnson (USA)
  • Table 164: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ million)
  • Table 165: First Quarter Sales Analysis by Segment:2007 Vs. 2006 (In US$ million)
  • Table 166: First Quarter Sales Analysis by GeographicRegion: 2007 Vs. 2006 (In US$ million)
  • Table 167: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
  • Table 168: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
  • Table 169: Annual Sales Analysis by Segment2006 Vs. 2005 (In US$ million)
  • Table 170: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
  • Ethicon, Inc. (USA)
  • Ethicon Endo-Surgery, Inc. (USA)
• 28. Karl Storz GmbH & Co., Kg (Germany)
  • Karl Storz Endoscopy-America, Inc. (USA)
• 29. Kay & Company (India)
• 30. Kytogenics Pharmaceuticals, Inc. (USA)
• 31. Laboratoire CCD (France)
• 32. Lifeline Systems Pvt., Ltd. (India)
• 33. Lumenis, Inc. (USA)
  • Table 171: Annual Sales Analysis: 2004-2005(In US$ million)
• 34. M. Lal International (India)
• 35. Marina Medical Instruments, Inc. (USA)
• 36. MD International, Inc. (USA)
• 37. MDMI Technologies, Inc. (Canada)
• 38. Medical Measurement Systems (MMS) (USA)
• 39. Medigus Ltd. (Israel)
• 40. Medtronic, Inc. (USA)
  • Table 172: Half Yearly Sales Analysis:2007 Vs. 2006 (H1) (In US$ million)
  • Table 173: Half Yearly Sales Analysis by Quarter:2007 Vs. 2006 (H1) (In US$ million)
  • Table 174: Half Yearly Sales Analysis by BusinessSegment: 2007 Vs. 2006 (H1) (In US$ million)
  • Table 175: Half Yearly Sales Analysis by GeographicRegion: 2007 Vs. 2006 (H1) (In US$ million)
  • Table 176: Annual Sales Analysis: 2004-2006(In US$ million)
  • Table 177: Annual Sales Analysis by BusinessSegment: 2006 Vs. 2005 (In US$ million)
  • Table 178: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
  • Table 179: Annual Sales Analysis by BusinessSegment: 2005 Vs. 2004 (In US$ million)
  • Table 180: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
• 41. Mentor Corporation (USA)
  • Table 181: Half Yearly Sales Analysis:2007 Vs. 2006 (H1) (In US$ million)
  • Table 182: Half Yearly Sales Analysis by Quarter:2007 Vs. 2006 (H1) (In US$ million)
  • Table 183: Half Yearly Sales Analysis by Product:2007 Vs. 2006 (H1) (In US$ million)
  • Table 184: Annual Sales Analysis: 2004-2006(In US$ million)
  • Table 185: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
  • Table 186: Annual Sales Analysis by Product:2006 Vs. 2005 (In US$ million)
  • Table 187: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
  • Table 188: Annual Sales Analysis by Product:2005 Vs. 2004 (In US$ million)
  • Table 189: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
• 42. MGB Endoskopische Geräte GmbH Berlin (Germany)
• 43. Microsulis Limited (United Kingdom)
• 44. Microsulis USA (USA)
• 45. Morton Medical Ltd. (UK)
• 46. Nidhi Meditech Systems (India)
• 47. Novasys Medical, Inc. (USA)
• 48. Olympus Corporation (Japan)
  • Table 190: Annual Sales Analysis: 2005-2006(In ¥ million)
  • Table 191: Annual Sales Analysis by Segment:2005-2006 (In ¥ million)
  • Table 192: Annual Sales Analysis by GeographicRegion: 2005-2006 (In ¥ million)
  • Table 193: Annual Sales Analysis by Segment:2004-2005 (In ¥ million)
  • Table 194: Annual Sales Analysis by GeographicRegion: 2004-2005 (In ¥ million)
  • Olympus America, Inc. (USA)
  • Olympus Surgical & Industrial America, Inc. (USA)
• 49. Omni-Tract® Surgical (USA)
• 50. Photomedex (USA)
  • Table 195: Half Yearly Sales Analysis:2005-2006 (H1) (In US$ million)
  • Table 196: Half Yearly Sales Analysis by Quarter:2005-2006 (H1) (In US$ million)
  • Table 197: Annual Sales Analysis: 2004-2005(In US$ million)
  • Table 198: Annual Sales Analysis by Segment:2004-2005 (In US$ million)
  • Table 199: Annual Sales Analysis by GeographicRegion: 2004-2005 (In US$ million)
• 51. ProSurg, Inc. (USA)
• 52. ProUroCare Medical, Inc. (USA)
• 53. Rema Medizintechnik GmbH (Germany)
• 54. Richard Wolf GmbH (Germany)
  • Richard Wolf Medical Instruments Corporation (USA)
• 55. Smith & Nephew PLC (UK)
  • Table 200: Annual Sales Analysis: 2004-2005(In £ million)
  • Table 201: Annual Sales Analysis by Segment:2004-2005 (In £ million)
  • Table 202: Annual Sales Analysis by GeographicRegion: 2004-2005 (In £ million)
• 56. Sofradim (France)
• 57. Stryker Corporation (USA)
  • Table 203: Annual Sales Analysis: 2004-2006(In US$ million)
  • Table 204: Annual Sales Analysis by Segment:2006 Vs. 2005 (In US$ million)
  • Table 205: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
  • Table 206: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
  • Table 207: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
  • Stryker Endoscopy Division (USA)
• 58. Synovis Life Technologies, Inc. (USA)
  • Table 208: Market Share by Segment:2006 (% Breakdown of Value Sales)
  • Table 209: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
  • Table 210: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
  • Table 211: Annual Sales Analysis by Segment:2006 Vs. 2005 (In US$ million)
• 59. Teleflex Medical Group (USA)
• 60. Tomed Dr. Toussaint GmbH (Germany)
• 61. U.S. Surgical (USA)
• 62. Urologix, Inc. (USA)
  • Table 212: Annual Sales Analysis: 2005-2006(In US$ million)
  • Table 213: Quarterly Sales Analysis: 2005-2006(In US$ million)
• 63. Uroplasty, Inc. (USA)
  • Table 214: Annual Sales Analysis: 2005-2006(In US$ million)
• 64. Utah Medical Products, Inc. (USA)
  • Table 215: Nine Months Sales Analysis: 2006 Vs. 2005(Nine Months Ended, September) (In US$ million)
  • Table 216: Nine Months Sales Analysis by Quarter:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
  • Table 217: Nine Months Sales Analysis by Segment:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
  • Table 218: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
  • Table 219: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
  • Table 220: Annual Sales Analysis by Segment: 2005 Vs.2004 (In US$ million)
  • Table 221: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
• 65. Vision Sciences, Inc. (USA)
  • Table 222: Annual Sales Analysis: 2005-2006(In US$ million)
  • Table 223: Annual Sales Analysis by GeographicRegion: 2004-2005 (In US$ million)
  • Table 224: Annual Sales Analysis by Segment:2004-2005 (In US$ million)
• 66. Wallach Surgical Devices, Inc. (USA)